Angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs) and beta-blockers did not show a significant beneficial effect in patients with heart failure with preserved ejection fraction (HF-PEF) [5], and their prognosis did not improve over the last years [6]. The gene discussed is ACE; the disease is hydrops fetalis.